Calio B, Kasson M, Sugano D, Ortman M, Gaitonde K, Verma S, Sidana A. 2018. Multiparametric MRI: An Opportunity for Focal Therapy of Prostate Cancer. Semin Roentgenol, 53 3, 227
Expert panel on urologic imaging: Froemming AT, Verma S, Eberhardt SC, Oto A, Alexander LF, Allen BC, Coakley FV, Davis BJ, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Wang CL, Remer EM. 2018. ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer. J Am Coll Radiol, 15 5S, S132
Kasson M, Ortman M, Gaitonde K, Verma S, Sidana A. 2018. Imaging Prostate Cancer Using Multiparametric Magnetic Resonance Imaging: Past, Present, and Future. Semin Roentgenol, 53 3, 200
Mullineux JH, Ivan CV, Pancholi J, Verma R, Rajesh A, Verma S, Stephenson JA. 2018. Benign Sclerosing and Fibrosing Conditions of the Abdomen and Their Potential Mimics. J Clin Imaging Sci, 8 May 31, 21
Sarkar S, Verma S. 2018. MR Imaging-Targeted Prostate Biopsies. Radiol Clin North Am., 56 2, 289
Verma S. 2018. Prostate MRI Update. Semin Roentgenol, 53 3, 199
Expert Panel on Urologic Imaging:, Coakley FV, Oto A, Alexander LF, Allen BC, Davis BJ, Froemming AT, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Verma S, Wang CL, Remer EM, Eberhardt SC. 2017. ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging. J Am Coll Radiol, 148 5S, S245
Expert Panel on Urologic Imaging:, Hosseinzadeh K, Oto A, Allen BC, Coakley FV, Friedman B, Fulgham PF, Hartman MS, Heller MT, Porter C, Sahni VA, Sudakoff GS, Verma S, Wang CL, Yoo DC, Remer EM, Eberhardt SC. 2017. ACR Appropriateness Criteria® Hematospermia. J Am Coll Radiol, 14 5S, S154
Rusu M, Purysko AS, Verma S, Kiechle J, Gollamudi J, Ghose S, Herrmann K, Gulani V, Paspulati R, Ponsky L, Böhm M, Haynes AM, Moses D, Shnier R, Delprado W, Thompson J, Stricker P, Madabhushi A. 2017. Computational imaging reveals shape differences between normal and malignant prostates on MRI. Sci Rep, 7 , 41261
Verma S, Choyke PL, Eberhardt SC, Oto A, Tempany CM, Turkbey B, Rosenkrantz AB. 2017. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer. Radiology, 285 2, 343
Verma S, Rosenkrantz AB, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS. 2017. Commentary regarding a recent collaborative consensus statement addressing prostate MRI and MRI-targeted biopsy in patients with a prior negative prostate biopsy. Abdom Radiol (NY), 42 2, 346
Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, Padhani AR, Margolis D, Macura KJ, Haider MA, Cornud F, Choyke PL. 2016. Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol, 69 1, 41
Jena, Amarnath; Taneja, Sangeeta; Gambhir, Aashish; Mishra, Anil Kumar; Dʼsouza, Maria Mathew; Verma, Sapna Manocha; Hazari, Puja Panwar; Negi, Pradeep; Jhadav, Ganesh Krishna Rao; Sogani, Shanti Kumar 2016. Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI. Clinical nuclear medicine, 41 5, e228-36
Jia JB, Houshyar R, Verma S, Uchio E, Lall C. 2016. Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology. Eur J Radiol, 85 1, 261
Jung BC, Tran NA, Verma S, Dutta R, Tung P, Mousa M, Hernandez-Rangel E, Nayyar M, Lall C. 2016. Cross-sectional imaging following surgical interventions for stress urinary incontinence in females. Abdom Radiol (NY), 41 6, 1178
Rosenkrantz AB, Verma S, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS. 2016. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. J Urol, 196 6, 1613
Verma S 2016. MRI of Prostate Cancer: Update. Top Magn Reson Imaging, 25 3, 101
Verma S, Sarkar S, Young J, Venkataraman R, Yang X, Bhavsar A, Patil N, Donovan J, Gaitonde K. 2016. Evaluation of the impact of computed high b-value diffusion-weighted imaging on prostate cancer detection. Abdom Radiol (NY), 41 5, 934
Wahab SA, Verma S 2016. Review of Prostate Imaging Reporting and Data System version 2. Future Oncol, 12 21, 2479
Westphalen AC, Verma S, Zagoria RJ. 2016. Is it time for prostate MRI certification? Abdom Radiol (NY), 41 5,
Wibmer A, Verma S, Vargas HA. 2016. Role of MRI in the Risk Assessment of Primary Prostate Cancer. Top Magn Reson Imaging, 25 3, 133
Yacoub JH, Oto A, Allen BC, Coakley FV, Friedman B, Hartman MS, Hosseinzadeh K, Porter C, Sahni VA, Sudakoff GS, Verma S, Wang CL, Remer EM, Eberhardt SC. 2016. ACR Appropriateness Criteria Staging of Testicular Malignancy. J Am Coll Radiol, 13 10, 1203
Lall C, Houshyar R, Landman J, Verma S, Goyenechea M, Bhargava P, Pulford C, Okhunov Z, Siaghani PJ, Menias C. 2015. Renal Collision and Composite Tumors: Imaging and Pathophysiology. Urology, 86 6, 1159
Liu X, Verma S. 2015. Common technical and anatomical pitfalls in the evaluation of multiparametric prostate magnetic resonance imaging. Semin Roentgenol, 50 4, 294
Parker RA 3rd, Menias CO, Quazi R, Hara AK, Verma S, Shaaban A, Siegel CL, Radmanesh A, Sandrasegaran K. 2015. MR Imaging of the Penis and Scrotum. Radiographics, 35 4, 1033
Rosenkrantz AB, Verma S, Turkbey B. 2015. Prostate cancer: top places where tumors hide on multiparametric MRI. AJR Am J Radiol, 204 4, W449
Bhavsar A, Verma S. 2014. Anatomic imaging of the prostate. Biomed Res Int, 2014 , 728439
Chiec L, Verma S, Kendler A, Abdel Karim N. 2014. Male pelvic squamous cell carcinoma of unknown primary origin. Case Reo Ibcik Ned, 2014 , 953698
Muller BG, Fütterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J, Moul JW, Pinto PA, Rastinehad AR, Robertson C, de la Rosette J, Sanchez-Salas R, Jones JS, Ukimura O, Verma S, Wijkstra H, Marberger M. 2014. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel. BJU Int, 113 2, 218
Reddy MN, Verma S. 2014. Lesions of the Seminal Vesicles and their MRI Characteristics. J Clin Imaging Sci, 4 61,
Sedlic T, Scali EP, Lee WK, Verma S, Chang SD. 2014. Inflammatory pseudotumours in the abdomen and pelvis: a pictorial essay. Can Assoc Radiol J, 65 1, 52
Verma S, Bhavsar AS, Donovan J. 2014. MR imaging-guided prostate biopsy techniques. Magn Reson Imaging Clin N Am, 22 2, 135
Bhavsar AS, Verma S, Lamba R, Lall CG, Koenigsknecht V, Rajesh A 2013. Abdominal manifestations of neurologic disorders Radiographics, 33 1, 135
Verma S, Rajesh A, Prasad SR, Gaitonde K, Lall CG, Mouraviev V, Aeron G, Bracken RB, Sandrasegaran K 2012. Urinary bladder cancer: role of MR imaging Radiographics, 32 2, 371
Verma S, Turkbey B, Muradyan N, Rajesh A, Cornud F, Haider MA, Choyke PL, Harisinghani M 2012. Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management AJR Am J Roentgenol, 198 6, 1277
Sinha R, Verma R, Verma S, Rajesh A 2011. MR enterography of Crohn disease: part 2, imaging and pathologic findings AJR Am J Roentgenol, 197 1, 80
Sinha R, Verma R, Verma S, Rajesh A 2011. MR enterography of Crohn disease: part 1, rationale, technique, and pitfalls AJR Am J Roentgenol, 197 1, 76
Verma S, Rajesh A 2011. A clinically relevant approach to imaging prostate cancer: self-assessment module AJR Am J Roentgenol, 196 3 Suppl, S11
Verma S, Rajesh A 2011. A clinically relevant approach to imaging prostate cancer: review AJR Am J Roentgenol, 196 3 Suppl, S1
Verma S, Rajesh A, Morales H, Lemen L, Bills G, Delworth M, Gaitonde K, Ying J, Samartunga R, Lamba M 2011. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy AJR Am J Roentgenol, 196 2, 374
Verma S, Rajesh A, Fütterer JJ, Turkbey B, Scheenen TW, Pang Y, Choyke PL, Kurhanewicz J. 2010. Prostate MRI and 3D MR spectroscopy: how we do it AJR Am J Roentgenol, 194 6, 1414
